Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Trial for the Canadian Right Ventricular AdaptiVE (CRAVE) Platform for Therapies Targeting Right Ventricular Failure

NCT06570473 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT06570473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06570473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Trial for the Canadian Right Ventricular AdaptiVE (CRAVE) Platform for Therapies Targeting Right Ventricular Failure
Lead sponsor
University of Alberta
Phase
Phase 2
Overall status
Recruiting
Start date
July 15, 2025
Completion date
December 31, 2026
Enrollment
30 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension, right heart failure, right ventricular dysfunction